UPDATE 1-Japan's Daiichi Sankyo to sell up to $3.6 bln Sun Pharma stake

April 20, 2015 1:25 PM

5 0

MUMBAI, April 20 (Reuters) - Japan's Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion in Indian drugmaker Sun Pharmaceutical Industries Ltd, setting it on course to retreat from India after a rollercoaster 7 years.

Daiichi bought India's Ranbaxy Laboratories Ltd in 2008, betting on growing global demand for generic drugs, but found itself saddled with a company battling complaints and sanctions from the U.S. Food and Drug Administration (FDA).

Also read: BAT offers to buy U.S. tobacco firm Reynolds in $47 billion deal

Read more

To category page